MedTech Daily Briefing
2026-07-17
|
Section 1: MedTech Industry News
DePuy Synthes adds spine implants with Expanding Innovations buy
MedTech Dive • July 16, 2026
|
Abbott reports diagnostics growth since $21B Exact Sciences buy
MedTech Dive • July 16, 2026
|
Zimmer Biomet names new Asia Pacific president
MedTech Dive • July 16, 2026
|
Abbott to launch Libre Duo dual sensor internationally in the fall, expects future reimbursement catalysts - MassDevice
MassDevice • July 16, 2026
|
Intuitive posts Q2 beats as surgical robot procedures grow 16% - MassDevice
MassDevice • July 16, 2026
|
Abbott raises 2026 EPS guidance on Q2 beats, several product launches planned - MassDevice
MassDevice • July 16, 2026
|
Boston Scientific Vascular Therapies head is leaving - MassDevice
MassDevice • July 17, 2026
|
Imperative Care launches new guidewire purpose-built for stroke - MassDevice
MassDevice • July 17, 2026
|
Medtronic completes $650M SPR Therapeutics acquisition - MassDevice
MassDevice • July 16, 2026
|
RapidPulse raises $48M for thrombectomy tech as Medtronic invests - MassDevice
MassDevice • July 16, 2026
|
Stryker fully launches Mako robotic power system for knee surgery in US - MassDevice
MassDevice • July 16, 2026
|
Medtronic, FDA pick up legal victories in spinal cord stimulator suits - MassDevice
MassDevice • July 16, 2026
|
GSK axes key cough drug candidate after phase 3 data end blockbuster hopes
Fierce Biotech • July 17, 2026
|
Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M deal
Fierce Biotech • July 17, 2026
|
Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 update
Fierce Biotech • July 16, 2026
|
Racing Takeda, InnoCare reports TYK2 inhibitor win in phase 2 vitiligo trial
Fierce Biotech • July 16, 2026
|
Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market
Fierce Biotech • July 16, 2026
|
Prosthetics developer Metacarpal seizes on reliability
Medical Design & Outsourcing • July 17, 2026
|
Sensors on surgeons helped J&J’s DePuy Synthes sell a new tool
Medical Design & Outsourcing • July 16, 2026
|
|
Section 2: National News — MedTech Relevant
|
Section 3: VC Press Releases
|
Section 4: Public Market Roundup — as of July 16, 2026
|
▲ Top Gainers
| ABT |
Abbott Laboratories |
+10.71% |
| DXCM |
DexCom |
+7.22% |
| CARL |
Carlsmed |
+6.68% |
|
|
▼ Top Losers
| HTFL |
Heartflow |
-4.70% |
| AVR |
Anteris |
-4.03% |
| CLPT |
ClearPoint |
-3.89% |
|
📅 Upcoming Earnings (Next 7 Days)
| EW |
Edwards Lifesciences |
July 23, 2026 |
|
|
MedTech Daily Briefing • Curated by automation
|
|